Posted by AGORACOM-JC
at 10:23 AM on Thursday, March 25th, 2021
Announced that it has launched, in the Apple App Store and on Google Play, the 2nd phase of its Liquid Avatar Mobile App program.
Updated phase, which builds on the program launch in February, introduces key features, and a host of minor technology and app updates.
Phase 2 will also see the introduction of multiple language capabilities with several languages being readied for rollout in the near future, the ability to connect further social media and data sources to their Liquid Avatar personas, and additional free Liquid Avatar creative components.
TORONTO, ON / March 25, 2021 /Liquid Avatar Technologies Inc. (CSE:LQID)(OTC PINK:TRWRF) (FRA:4T51) (“Liquid Avatar Technologies” or the “Company“), a global blockchain, digital identity and fintech solutions company is excited to announce that it has launched, in the Apple App Store and on Google Play, the 2nd phase of its Liquid Avatar Mobile App program.
This updated phase, which builds on the program launch in February, introduces key features, and a host of minor technology and app updates. This release will provide users with the ability to create multiple Liquid Avatars and manage different facets of their personalities (personas) as well as storing items in their personal locker. Phase 2 will also see the introduction of multiple language capabilities with several languages being readied for rollout in the near future, the ability to connect further social media and data sources to their Liquid Avatar personas, and additional free Liquid Avatar creative components.
The Company will continue to advance the product via its April release, which is expected to feature a first look at Liquid Avatar’s Verifiable Credentials Ecosystem, allowing users to create W3C compliant Verifiable Credentials in their Liquid Avatar wallet, with an initial focus on their Identity Verified Credential. Work also continues on a number of other key features including the integration of ImagineAR’s (CSE:IP / OTCQB:IPNFF) augmented reality platform that will provide unique immersive experiences for Liquid Avatar Mobile App users and Oasis Digital Studios’ AR Enhanced NFTs.
The Liquid Avatar beta app, featuring user created digital icons that allow users to manage, control and create value from their biometrically verified digital identity, officially launched globally in the Google Play and Apple App Store on February 18, 2021. With the foundational first and second phases now available, the Liquid Avatar app will continue to launch additional updates, features and phases, on a regular monthly basis. The Company believes that as it plans to provide future features, regular releases will provide users with the opportunity to familiarize themselves with existing features before moving on to more comprehensive services and the opportunity to manage their digital identity and verifiable credentials.
If you would like to join our mailing list and receive updates from the Company, please click here
Loncor Resources Inc. (“Loncor” or the “Company”) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce further significant assay results from its drilling program within its 84.68%-owned Imbo Project in the eastern part of the Ngayu greenstone belt in the Democratic Republic of the Congo. The deepest borehole drilled to date at its flagship Adumbi deposit, LADD009 intersected 32.15 metres grading 6.17 grammes per tonne (g/t) gold (including 1.46 metres grading 94.77 g/t Au), 15.36 metres grading 3.73 g/t gold (including 5.89 metres grading 6.56 g/t Au), 5.00 metres grading 3.17 g/t gold and 7.45 metres grading 1.48 g/t gold.
Mineralized sections for borehole LADD009 are summarised in the table below:
Borehole Number
From (m)
To (m)
Intersected Width (m)
Grade (g/t) Au
LADD009
559.76
564.76
5.00
3.17
LADD009
581.90
614.05
32.15
6.17
LADD009 including
599.05
600.51
1.46
94.77
LADD009
629.56
644.92
15.36
3.73
LADD009 including
632.00
637.89
5.89
6.56
LADD009
650.50
657.95
7.45
1.48
Borehole LADD009 had an inclination of minus 75 degrees and azimuth of 218 degrees at the start of hole and regular measurements of inclination and azimuth were taken at 30 metre intervals down the hole. All core was orientated, and it is estimated that the true widths of the mineralised sections are approximately 82% of the intersected width. All intercepted grades are uncut with maximum internal dilution equal to or less than 4 metres of intersected width. Borehole LADD009 intersected the mineralization at a depth of approximately 140 metres below the open pit shell (see Figures 2 and 3 below). Boreholes LADD012 and LADD013 are currently being drilled (LADD011 was abandoned before reaching target depth due to mechanical problems and LADD013 is being drilled in its place).
Commenting on these latest drilling results, Loncor President Peter Cowley said: “Borehole LADD009 is the deepest hole drilled to date at Adumbi as well as the highest value in terms of the product of grade multiplied by true width for the multiple intersections (see Figure 2). These excellent results combined with previous results from the ongoing drilling program indicate that gold grades are increasing with depth. We continue to be excited by the results at Adumbi. The holes from our current drilling program have intersected significant widths and grades and will increase the current open pittable, inferred mineral resource of 2.19 million ounces (28.97 million tonnes grading 2.35 g/t gold) at the Adumbi deposit. Studies are underway to quantify this increase.”
The gold mineralization at Adumbi is associated with a thick package (up to 130 metres) of interbedded banded ironstone and quartz carbonate and chlorite schist with higher grade sections being found in a strongly altered siliceous unit termed “Replaced Rock” (RP) where structural deformation and alteration has completely destroyed the primary host lithological fabric. Disseminated sulphide assemblages include pyrite, pyrrhotite and arsenopyrite which can attain up to 20% of the total rock in places.
The objective of the current drilling program at Adumbi is to outline additional mineral resources to the current inferred mineral resource of 2.5 million ounces of gold on Loncor’s 84.68%-owned Imbo Project which contains the Adumbi, Kitenge and Manzako deposits (inferred mineral resources of 30.65 million tonnes grading 2.54 g/t Au).
Posted by AGORACOM-JC
at 7:00 PM on Wednesday, March 24th, 2021
Intends to implement a normal course issuer bid (“NCIB”) through the facilities of the Canadian Securities Exchange (CSE) or alternative trading systems.
On any given day, during the NCIB, Kontrol may only purchase up to 69,500 common shares, which is equivalent to 25% of the Average Daily Trading Volume of 278,000 calculated based on the trading volumes on the CSE over the past 12 months and may purchase once per calendar week, in a block trade, a greater number of Common Shares.
TORONTO , March 24, 2021 – Kontrol Technologies Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) (” Kontrol Technologies ” or ” Kontrol ” or ” Company “) is pleased to announce today that it intends to implement a normal course issuer bid (“NCIB”) through the facilities of the Canadian Securities Exchange (CSE) or alternative trading systems.
Pursuant to the NCIB, Kontrol may purchase, from time to time, over a period of 12 months starting March 25, 2021 and ending March 25, 2022 , up to 2,061,236 common shares (approx. 5% of its common shares issued and outstanding as of March 24, 2021 ). As of March 24, 2021 , there were 41,224,731 common shares of Kontrol issued and outstanding. On any given day, during the NCIB, Kontrol may only purchase up to 69,500 common shares, which is equivalent to 25% of the Average Daily Trading Volume of 278,000 calculated based on the trading volumes on the CSE over the past 12 months and may purchase once per calendar week, in a block trade, a greater number of Common Shares.
Purchases under the NCIB may commence as of March 25, 2021 and will end on the earlier of: (i) March 25, 2022 ; or (ii) the date on which the Company has purchased the maximum number of common shares to be acquired under the NCIB. All purchases made by the Company will be through PI Financial Corporation acting on behalf of the Company. The purchases will be made in accordance with the rules of the CSE, through the facilities of the CSE or through alternative trading systems. The actual number of common shares which will be purchased, and the timing of such purchases, will be determined by the Company, and the price which the Company will pay for the common shares will be the market price at the time of the purchase. The common shares purchased under the NCIB will be cancelled.
The Company’s Board of Directors believes that the market price of the Company’s common shares may from time to time not reflect the underlying value of the Company, specifically its growth opportunities, and that the proposed purchasing of its common shares is in the best interests of the Company and represents an appropriate use of corporate funds. It is expected that any purchases made by the Company could also enhance value and liquidity for its shareholders.
Of note, this NCIB is further to a previous NCIB that the Company had implemented while trading under the CSE. Under the previous NCIB, which started on July 8, 2019 and ended on July 8, 2020 , 1,464,156 common shares were approved for purchase, of which 30,500 common shares were purchased. The weighted average price paid per common share purchased was $0.58 CDN.
About Kontrol Technologies Corp.
Kontrol Technologies Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
Additional information about Kontrol Technologies Corp. can be found on its website at www.kontrolcorp.com and by reviewing its profile on SEDAR at www.sedar.com .
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud are subject to the risk that the Kontrol BioCloud may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications. KontrolBioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Posted by AGORACOM-JC
at 4:07 PM on Wednesday, March 24th, 2021
If there’s one thing we know about governments at every level – whether local, state or federal – it’s that they can be hugely inefficient and can struggle to communicate.
Enter HealthSpace Data Systems (CSE: HS) (OTCQB: HDSLF) (Frankfurt: 38H). The company’s “empowering government efficiency” solution has empowered them to become an industry leading tech pioneer, providing both enterprise- and mobile internet-based applications to more than 500 state and local government organizations in North America. Including in:
Sonoma County, California
Jackson County, Missouri
Illinois
Wisconsin
Ontario, Canada
HealthSpace currently offers the only integrated product suite to incorporate inspection, administration and analytics across all platforms in North America.
A cloud-based and mobile platform helps revolutionize every aspect of government regulatory work
including licensing and inspections, accounting, even disease surveillance.
It has now entered into the FinTech space with a payment platform that streamlines the intake of government revenue for the agencies it serves. Furthermore, it has begun delivering its government-grade tech to private businesses, enabling them to add visibility and predictability into their own organizational structures.
And underpinning its innovation is a robust business model:
Scalable with Strong Pipeline of Organic Growth
Fully funded and built to execute on all-time high sales pipeline of >$18m and growing
Sticky and Diversified Customer Base: Over 98% client retention year-over-year
Predictable Recurring Revenues, targeting $10m (Over 100% from YE2020) in Annual Recurring Revenue within 12 to 18 months
We sat down with HealthSpace CEO Silas Garrison for a deeper dive:
The North America Unmanned Aerial Vehicle market was valued at $USD 1.7 billion in 2017 and is likely to exceed $USD 7 billion by 2024 (Global Market Insights)
Posted by AGORACOM-JC
at 8:56 AM on Wednesday, March 24th, 2021
Announced its participation in the Benzinga Biotech Small Cap Conference a virtual conference taking place on March 25th, 2021.
On Thursday, March 25th, at 9:25am EST, Novamind’s CEO and Director, Yaron Conforti, will present the Company’s vision for scaling access to psychedelic medicine.
Panel discussion on psychedelic treatments and therapies to feature Novamind’s Chief Medical Officer
Toronto, Ontario–(March 24, 2021) – Novamind Inc. (CSE: NM) (OTC Pink: NVMDF) (FSE: HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is pleased to announce its participation in the Benzinga Biotech Small Cap Conference (“the Conference”), a virtual conference taking place on March 25th, 2021.
On Thursday, March 25th, at 9:25am EST, Novamind’s CEO and Director, Yaron Conforti, will present the Company’s vision for scaling access to psychedelic medicine.
“Novamind’s mental health clinics and contract research businesses have been operating with psychedelic medicine since 2016, and both businesses are currently experiencing significant growth,” stated Yaron Conforti, CEO and Director of Novamind. “Our recently announced agreement to act as a key clinical trial site for Merck is one of many developments we’re excited to share with investors.”
The Conference will also host a panel discussion on the use of psychedelic therapies with industry leaders including Novamind’s Chief Medical Officer, Dr. Reid Robison on Thursday, March 25th at 1:10pm EST.
For more information about the conference, please click here.
About Novamind
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.
Contact Information
Novamind Yaron Conforti, CEO and Director Telephone: +1 (647) 953 9512
This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.
